The independent committee said the booster dose should be given at least six months after the initial two-dose vaccination series.
The Centers for Disease Control and Prevention’s vaccine advisory committee has endorsed the use of Pfizer and BioNTech’s Covid-19 booster shot for elderly people and those who may be at risk of developing severe disease, a move that could allow broad latitude for people to access additional doses.
